Biopharmaceuticals, an Industrial Perspective [E-Book] / edited by Gary Walsh, Brendan Murphy.
Biopharmaceuticals, an Industrial Perspective provides a unique and up-to-date insight into the biopharmaceutical industry. Largely written by industrial authors, its scope is multidisciplinary. Several chapters overview the production and medical applications of specific biopharmaceuticals. Other c...
Saved in:
Full text |
|
Personal Name(s): | Murphy, Brendan, editor |
Walsh, Gary, editor | |
Imprint: |
Dordrecht :
Springer Netherlands,
1999
|
Physical Description: |
X, 514 p. online resource. |
Note: |
englisch |
ISBN: |
9789401709262 |
DOI: |
10.1007/978-94-017-0926-2 |
Subject (LOC): |
- Biopharmaceuticals, an overview
- Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist
- Recombinant Coagulation Factor IX (BeneFix®)
- Biopharmaceutical Drug Development: A Case History
- Follitropin beta (Puregon)
- Insulin Lispro (Humalog)
- Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)
- Reteplase, a recombinant plasminogen activator
- Stabilisation of biopharmaceutical products and finished product formulations
- Patent Law for Biopharmaceuticals
- The development of new medicines: an overview
- The EMEA and regulatory control of (bio)pharmaceuticals within the European Union
- Biopharmaceutical Validation: an overview
- Validation of Biopharmaceutical Chromatography Systems
- Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture
- Information retrieval and the biopharmaceutical industry: an introductory overview
- Information technology and the internet as a resource of biopharmaceutical information
- Marketing Issues for the (Bio)pharmaceutical sector
- Viral mediated gene therapy
- Pharmaceutical gene medicines for non-viral gene therapy.